BIIB vs UTMD · P/E 21, rev $9.89B vs P/E 15, rev $17.3M
Biogen Inc (BIIB) versus Utah Medical Products Inc (UTMD) — a side-by-side from cached financials, not a winner call.
Biogen Inc (BIIB) is a drug manufacturers - general company listed on NASDAQ. It is led by Christopher A. Viehbacher.
Utah Medical Products Inc (UTMD) is a medical instruments & supplies company listed on US.
Latest reported BIIB revenue for 2025-12-31 was $9.89B. Net income was $1.29B. Revenue was up 2.2% from 2024-12-31 to 2025-12-31. BIIB currently screens at market cap $29.33B and trailing P/E 21.4.
Latest reported UTMD revenue for 2026-06-30 was $17.3M. Net income was $5.3M. Revenue was up 97.8% from 2026-03-31 to 2026-06-30. UTMD currently screens at market cap $189.8M and trailing P/E 15.4.
BIIB currently screens at market cap $29.33B and trailing P/E 21.4. UTMD currently screens at market cap $189.8M and trailing P/E 15.4.
Not investment advice. Open the BIIB and UTMD stock pages for the full models.
Not investment advice.